MM Health Podcast, 1 November 2020

Welcome to the MM Health Podcast. Today we discuss three articles in the Pharmaceutical Journal from the past two weeks. 

The first one is a “white paper” from Reckitt Benckiser, presented under the title, “Presenting the GI evidence of ibuprofen.” The second relates to the planned use of an unlicensed flu vaccine, FluBlok, within the UK from December 2020. The last section discusses developments in commercial testing for Covid-19 antibodies within the UK retail pharmacy market.